BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38239314)

  • 1. A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate Cancer.
    Radoiu C; Govindarajan B; Wang M; Sbrissa D; Cher ML; Chinni SR
    Med Res Arch; 2023 Jul; 11(7.1):. PubMed ID: 38239314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.
    Govindarajan B; Sbrissa D; Pressprich M; Kim S; Rishi AK; Vaishampayan U; Cher ML; Chinni SR
    Sci Rep; 2023 Nov; 13(1):20634. PubMed ID: 37996444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.
    Govindarajan B; Sbrissa D; Pressprich M; Kim S; Vaishampayan U; Cher ML; Chinni S
    Res Sq; 2023 Feb; ():. PubMed ID: 36865146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.
    Sbrissa D; Semaan L; Govindarajan B; Li Y; Caruthers NJ; Stemmer PM; Cher ML; Sethi S; Vaishampayan U; Shisheva A; Chinni SR
    Oncogene; 2019 Jan; 38(3):332-344. PubMed ID: 30111818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the conserved roles of PI4KA and its regulatory partners and their misregulation in disease.
    Suresh S; Burke JE
    Adv Biol Regul; 2023 Dec; 90():100996. PubMed ID: 37979461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.
    Chinni SR; Yamamoto H; Dong Z; Sabbota A; Bonfil RD; Cher ML
    Mol Cancer Res; 2008 Mar; 6(3):446-57. PubMed ID: 18337451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase IIIα and Oxysterol-Binding Protein.
    Dorobantu CM; Albulescu L; Lyoo H; van Kampen M; De Francesco R; Lohmann V; Harak C; van der Schaar HM; Strating JR; Gorbalenya AE; van Kuppeveld FJ
    mSphere; 2016; 1(3):. PubMed ID: 27303747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases.
    Barlow-Busch I; Shaw AL; Burke JE
    Curr Opin Cell Biol; 2023 Aug; 83():102207. PubMed ID: 37453227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.
    Rafiei S; Gui B; Wu J; Liu XS; Kibel AS; Jia L
    Mol Cancer Res; 2019 Jan; 17(1):263-276. PubMed ID: 30224544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI(4,5)P
    Sohn M; Korzeniowski M; Zewe JP; Wills RC; Hammond GRV; Humpolickova J; Vrzal L; Chalupska D; Veverka V; Fairn GD; Boura E; Balla T
    J Cell Biol; 2018 May; 217(5):1797-1813. PubMed ID: 29472386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.
    Berger KL; Kelly SM; Jordan TX; Tartell MA; Randall G
    J Virol; 2011 Sep; 85(17):8870-83. PubMed ID: 21697487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
    Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
    Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.
    Frigo DE; Sherk AB; Wittmann BM; Norris JD; Wang Q; Joseph JD; Toner AP; Brown M; McDonnell DP
    Mol Endocrinol; 2009 Sep; 23(9):1385-96. PubMed ID: 19460858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of PI4P levels by PI4KIIIα during G-protein-coupled PLC signaling in
    Balakrishnan SS; Basu U; Shinde D; Thakur R; Jaiswal M; Raghu P
    J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 29980590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.
    Conley-LaComb MK; Semaan L; Singareddy R; Li Y; Heath EI; Kim S; Cher ML; Chinni SR
    Mol Cancer; 2016 Nov; 15(1):68. PubMed ID: 27809841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CXCR4 in multiple myeloma: Cells' journey from bone marrow to beyond.
    Ullah TR
    J Bone Oncol; 2019 Aug; 17():100253. PubMed ID: 31372333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.
    Crawford ED; Higano CS; Shore ND; Hussain M; Petrylak DP
    J Urol; 2015 Dec; 194(6):1537-47. PubMed ID: 26196735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.